StockData
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. (AVXL) KPIs and segments

AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.72−0.02 (-2.78%)

Close on Nov 18, 2026Market cap $66.69MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Anavex Life Sciences's business

Coming soon

This tab will track the numbers specific to Anavex Life Sciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?